Spencer C. Fleischer - Dec 31, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 31, 2021
Transactions value $
$30,687
Form type
4
Date filed
1/4/2022, 03:18 PM
Previous filing
Nov 18, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $30.7K +176 +15.59% $174.36 1.31K Dec 31, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +67.5 +0.7% $0.00 9.69K Nov 10, 2021 Common Stock 67.5 Direct F2, F3, F4
transaction CLX Deferred Stock Units Award $0 +919 +9.48% $0.00 10.6K Dec 31, 2021 Common Stock 919 Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F5 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.